Companies / AEON Biopharma, Inc.

AEON Biopharma, Inc.

NYSE: AEONCIK 1837607ALISO VIEJO, CA

Financials

Revenue
Net income$-39.22M
Total debt
Cash$3.43M
Diluted EPS$-3.95
Shares outstanding49.9M

Ownership

49.9M shares outstanding · as of Aug 6, 2026
16.3%Insiders
Ownership
Insiders16.29%8,127,299
Institutions4.97%2,481,485
Public float78.73%39,274,006

% of common shares outstanding (exact, from the latest cover-page filing). Institutions are quarterly 13F snapshots; insiders reflect current officers & directors.

Insiders 9

View all →
Insider% of sharesShares
Bancroft Robert E.CEOPRESIDENT & CEO · Director
6.37%3,177,103
Oh ChadCHIEF MEDICAL OFFICER
4.38%2,183,436
Wilson Alexander BlairFormerCLO, CSO, and Corp Secretary
4.38%2,183,005
Sy JenniferPRINCIPAL ACCOUNTING OFFICER
3.01%1,501,176
Fischer JostDirector
0.98%489,469
0.52%258,705
0.52%258,705
0.52%258,705

Institutional holders 24

View all →

Activity

Jun 30, 2026View all →
InsidersInstitutions
Who's accumulating and trimming this stock (13F).
DateActorActionSecurityValueShares ΔPosition afterImpact
Q1 2026
as of
Geode Capital Management, LLC
13F manager
AddCommon Stock$26.5K+27K
+44.78%
87,062
0.17% of shares
low
Q2 2026
as of
LPL Financial LLC
13F manager
NewCommon Stock$8.3K+12K
11,507
0.02% of shares
low
Q3 2025
as of
Barclays PLC
13F manager
NewCommon Stock$17+21
21
<0.01% of shares
low
Q4 2025
as of
Barclays PLC
13F manager
ExitCommon Stock$-17-21
-100.00%
0
low
Q4 2025
as of
Bank of America Corp /De
13F manager
AddCommon Stock$7+6
+0.25%
2,382
<0.01% of shares
low
Q4 2025
as of
Danske Bank A/S
13F manager
NewCommon Stock$1+1
1
<0.01% of shares
low

Securities

via CUSIP / OpenFIGI
SymbolTypeMarketCUSIPFIGI
AEONCommon StockEquity00791X209BBG00Z17HDW3